Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 55Carcinoma, Hepatocellular 40Neoplasms 38Polycystic Ovary Syndrome 27Colorectal Neoplasms 24Stomach Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Prostatic Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Recurrence 13Pancreatic Neoplasms 13Lymphoma 13Liver Neoplasms 13Urinary Bladder Neoplasms 11Leukemia, Myeloid, Acute 11Esophageal Neoplasms 11Leiomyoma 10Colonic Neoplasms 10Pain 9Lung Neoplasms 9Multiple Myeloma 8Uterine Cervical Neoplasms 7Neoplasm Metastasis 7Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Keratosis, Actinic 7Infertility 7Papillomavirus Infections 6Pain, Postoperative 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

Herpes Zoster Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Herpes Zoster × Clear all
NCT02444936 2018-04-06

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

Louis Stokes VA Medical Center

Phase 4 Unknown
22 enrolled 8 charts

Herpes Zoster

Data powered by HemOnc (CC BY 4.0) Colophon âš¡